# Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation

> **NCT03513029** · NA · UNKNOWN · sponsor: **VytronUS, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** VytronUS Ablation System

## Key facts

- **NCT ID:** NCT03513029
- **Lead sponsor:** VytronUS, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-20
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513029, "Clinical Investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03513029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*